The objective was to update previous evidence‐based medicine reviews of treatments for
motor symptoms of Parkinson's disease published between 2002 and 2005. Level I (…

Objective: The objective of this review was to update evidence‐based medicine recommendations
for treating motor symptoms of Parkinson's disease (PD). Background: The Movement …

Objective To update evidence‐based medicine recommendations for treating nonmotor
symptoms in Parkinson's disease (PD). Background The International Parkinson and Movement …

Evidence for a close bidirectional link between the brain and the gut has led to a paradigm
shift in neurology, especially in the case of Parkinson disease (PD), in which gastrointestinal …

Noncoding repeat expansions cause various neuromuscular diseases, including myotonic
dystrophies, fragile X tremor/ataxia syndrome, some spinocerebellar ataxias, amyotrophic …

Background Recent studies reported a high prevalence of small intestinal bacterial overgrowth
(SIBO) in Parkinson's disease (PD), and a possible association with gastrointestinal …

In recent years, there has been increasing recognition of the features of Parkinson disease
that are not related to nigrostriatal dopamine deficiency. This review addresses selected …

Data regarding the effect of deep brain stimulation (DBS) surgery on the dopamine dysregulation
syndrome (DDS), impulse control disorders (ICDs) and punding in Parkinson’s disease …

Objective To determine whether probiotics are effective for constipation, a common and
often difficult-to-treat problem, in Parkinson disease (PD). Methods In this double-blind, …

Nonmotor symptoms (NMS) are very common in Parkinson's disease (PD) and may result in
significant disability. The increased focus on these important clinical features represents a …